Total Payments
$9,292
2022 Payments
$70.08
Companies
23
Transactions
598
Medicare Patients
211
Medicare Billing
$91,403
Payment Breakdown by Category
Food & Beverage$9,148 (98.5%)
Education$129.63 (1.4%)
Other$13.68 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,148 | 587 | 98.5% |
| Education | $129.63 | 10 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13.68 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $2,030 | 125 | $0 (2020) |
| Allergan, Inc. | $1,338 | 95 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $1,270 | 76 | $0 (2021) |
| Shire North American Group Inc | $875.41 | 84 | $0 (2019) |
| Alkermes, Inc. | $662.47 | 34 | $0 (2020) |
| Lundbeck LLC | $642.33 | 48 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $354.55 | 17 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $315.02 | 16 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $291.82 | 21 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $247.42 | 19 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $70.08 | 1 | ABBVIE INC. ($70.08) |
| 2021 | $215.39 | 14 | Janssen Pharmaceuticals, Inc ($149.77) |
| 2020 | $1,889 | 112 | Allergan, Inc. ($353.84) |
| 2019 | $3,080 | 196 | Otsuka America Pharmaceutical, Inc. ($725.81) |
| 2018 | $2,112 | 142 | Otsuka America Pharmaceutical, Inc. ($494.83) |
| 2017 | $1,926 | 133 | Otsuka America Pharmaceutical, Inc. ($470.65) |
All Payment Transactions
598 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/28/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $70.08 | General |
| Category: NEUROSCIENCE | ||||||
| 12/21/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: Neuroscience | ||||||
| 11/22/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: Neuroscience | ||||||
| 10/06/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: Neuroscience | ||||||
| 09/27/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Neuroscience | ||||||
| 09/11/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Neuroscience | ||||||
| 09/07/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: Neuroscience | ||||||
| 05/10/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Neuroscience | ||||||
| 05/03/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Neuroscience | ||||||
| 04/14/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Neuroscience | ||||||
| 03/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: NEUROSCIENCE | ||||||
| 02/12/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $34.13 | General |
| Category: Neuroscience | ||||||
| 11/23/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Neuroscience | ||||||
| 11/12/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: Neuroscience | ||||||
| 11/11/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Neuroscience | ||||||
| 10/30/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2020 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 10/26/2020 | Lundbeck LLC | REXULTI (Drug) | Education | In-kind items and services | $1.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $16.19 | General |
| Category: Neurology | ||||||
| 10/24/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: CNS | ||||||
| 10/22/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 83 | 418 | $116,612 | $39,120 |
| 2020 | 1 | 128 | 647 | $106,044 | $52,284 |
Total Patients
211
Total Services
1,065
Medicare Billing
$91,403
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 351 | $101,976 | $32,200 | 31.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 31 | $12,085 | $4,683 | 38.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 11 | 36 | $2,551 | $2,237 | 87.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 128 | 647 | $106,044 | $52,284 | 49.3% |
About Dr. Thomas Mclaughlin, MD
Dr. Thomas Mclaughlin, MD is a Psychiatry healthcare provider based in Lawrence, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518062827.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Mclaughlin, MD has received a total of $9,292 in payments from pharmaceutical and medical device companies, with $70.08 received in 2022. These payments were reported across 598 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($9,148).
As a Medicare-enrolled provider, Mclaughlin has provided services to 211 Medicare beneficiaries, totaling 1,065 services with total Medicare billing of $91,403. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Lawrence, MA
- Active Since 09/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1518062827
Products in Payments
- REXULTI (Drug) $1,686
- VRAYLAR (Drug) $1,315
- INVEGA SUSTENNA (Drug) $782.43
- VYVANSE (Drug) $635.53
- ABILIFY MAINTENA (Drug) $513.65
- SPRAVATO (Drug) $438.19
- ARISTADA (Drug) $417.15
- TRINTELLIX (Drug) $370.14
- AUSTEDO (Drug) $354.55
- MYDAYIS (Drug) $304.74
- LATUDA (Drug) $291.82
- Adzenys XR-ODT (Drug) $245.01
- INGREZZA (Drug) $201.84
- BRINTELLIX (Drug) $198.78
- Aristada 441 mg (Drug) $178.21
- NUEDEXTA (Drug) $155.76
- BELSOMRA (Drug) $110.89
- SUBOXONE SUBLINGUAL FILM (Drug) $109.33
- Fanapt (Drug) $107.94
- SUBLOCADE (Drug) $100.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lawrence
Dr. Taylor Porter, M.d, M.D
Psychiatry — Payments: $47,074
Psychiatry $47,074
Hiten Soni, M.d, M.D
Psychiatry — Payments: $5,156
Psychiatry $5,156
Jennifer Albert, M.d, M.D
Psychiatry — Payments: $3,295
Psychiatry $3,295
Dr. Nicholas Evangelidis, M.d, M.D
Psychiatry — Payments: $1,935
Psychiatry $1,935
Dr. Cord Huston, M.d, M.D
Psychiatry — Payments: $1,826
Psychiatry $1,826
Dagoberto Heredia
Psychiatry — Payments: $1,732
Psychiatry $1,732